<!DOCTYPE html>
<html lang="en-us">
  <head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <title>A chromatin-mediated reversible drug tolerant state in cancer cell subpopulations | Just for your understanding</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <script data-ad-client="ca-pub-5931609864546180" async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
  </head>

  <body>
    <nav>
    <ul class="menu">
      
      <li><a href="/">Home</a></li>
      
      <li><a href="/about/">About</a></li>
      
      <li><a href="/categories/">Categories</a></li>
      
      <li><a href="/tags/">Tags</a></li>
      
      <li><a href="/index.xml">Subscribe</a></li>
      
    </ul>
    <hr/>
    </nav>

<div class="article-meta">
<h1><span class="title">A chromatin-mediated reversible drug tolerant state in cancer cell subpopulations</span></h1>
<h2 class="author">Jeff Settlman</h2>
<h2 class="date">2020/05/08</h2>
</div>

<main>
<h1 id="citation">Citation</h1>
<p>Sharma, S. V., Lee, D. Y., Li, B., Quinlan, M. P., Takahashi, F., Maheswaran, S., McDermott, U., Azizian, N., Zou, L., Fischbach, M. A., Wong, K. K., Brandstetter, K., Wittner, B., Ramaswamy, S., Classon, M., &amp; Settleman, J. (2010). A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell, 141(1), 69–80. <a href="https://doi.org/10.1016/j.cell.2010.02.027">https://doi.org/10.1016/j.cell.2010.02.027</a></p>
<h1 id="abstract">Abstract</h1>
<p>Accumulating evidence implicates heterogeneity within cancer cell populations in the response to stressful exposures, including drug treatments. While modeling the acute response to various anti-cancer agents in drug-sensitive human tumor cell lines, we consistently detected a small subpopulation of reversibly “drug-tolerant” cells. These cells demonstrate &gt;100-fold reduced drug sensitivity, and maintain viability via engagement of IGF-1 receptor signaling and an altered chromatin state that requires the histone demethylase RBP2/KDM5A/Jarid1A. This drug-tolerant phenotype is transiently acquired and relinquished at low frequency by individual cells within the population, implicating the dynamic regulation of phenotypic heterogeneity in drug tolerance. The drug-tolerant subpopulation can be selectively ablated by treatment with IGF-1 receptor inhibitors or chromatin-modifying agents, potentially yielding a therapeutic opportunity. Together, these findings suggest that cancer cell populations employ a dynamic survival strategy in which individual cells transiently assume a reversibly drug-tolerant state to protect the population from eradication by potentially lethal exposures.</p>
<h1 id="major-results">Major results:</h1>

</main>

  <footer>
  <script src="//yihui.name/js/math-code.js"></script>
<script async src="//cdn.bootcss.com/mathjax/2.7.1/MathJax.js?config=TeX-MML-AM_CHTML"></script>

<script async src="//yihui.name/js/center-img.js"></script>

  
  <hr/>
  © <a href="https://zijzhang.netlify.com">Zijian Zhang</a> 2018 &ndash; 2019 | <a href="https://github.com/zijzhang">Github</a>
  
  </footer>
  </body>
</html>

